Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
14,98 USD | +1,97% | +3,93% | +38,50% |
14:00 | Immunome, Inc. nomme Kinney Horn au poste de Chief Business Officer | CI |
30/04 | IMMUNOME, INC. : Opinion positive de JPMorgan Chase | ZM |
Métier
Nombre d'employés: 55
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Biotechnology
100,0
%
| 0 | nan % | 14 | 100,0 % | - |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 14 | 100,0 % | - |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Clay Siegall
CEO | Chief Executive Officer | 63 | 02/10/23 |
Max Rosett
DFI | Director of Finance/CFO | 34 | 02/10/23 |
Bob Lechleider
CTO | Chief Tech/Sci/R&D Officer | 63 | 19/10/23 |
Matthew Robinson
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/03/16 |
Jack Higgins
CTO | Chief Tech/Sci/R&D Officer | 45 | 02/10/23 |
Philip Wagenheim
BRD | Director/Board Member | 53 | 01/01/17 |
Robert Lapetina
AUD | Comptroller/Controller/Auditor | 49 | 01/05/21 |
Bruce Turner
PRN | Corporate Officer/Principal | 60 | 02/10/23 |
Sandra Stoneman
LAW | General Counsel | 51 | 10/12/20 |
Kinney Horn
PRN | Corporate Officer/Principal | 49 | 01/02 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Carol Schafer
BRD | Director/Board Member | 60 | 02/01 |
Director/Board Member | 70 | 07/11 | |
Clay Siegall
CEO | Chief Executive Officer | 63 | 02/10/23 |
Philip Wagenheim
BRD | Director/Board Member | 53 | 01/01/17 |
James Boylan
BRD | Director/Board Member | 57 | 02/10/23 |
Isaac Barchas
BRD | Director/Board Member | 56 | 02/10/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 59 943 368 | 49 138 414 ( 81,97 %) | 0 | 81,97 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+38,50% | 881 M | |
-1,42% | 104 Md | |
+7,05% | 97,47 Md | |
+5,71% | 22,25 Md | |
-12,60% | 21,68 Md | |
-9,70% | 18,2 Md | |
-39,98% | 17,02 Md | |
-10,51% | 16,36 Md | |
+7,41% | 14,39 Md | |
+37,47% | 12,37 Md |
- Bourse
- Actions
- Action IMNM
- Société Immunome, Inc.